Target intelligence / Profile preview

Solute carrier family 50 member 1 (SLC50A1)

Target
SLC50A1
Molecular classification
Transporter
01

Overview

Solute carrier family 50 member 1 (SLC50A1) encodes a broadly expressed transmembrane sugar transporter, also known as SWEET1, that mediates glucose and possibly other sugar transport across cellular membranes[1][3][4]. It is the only member of the SWEET transporter family in humans, and has roles in carbohydrate transport in various tissues, including potential involvement in mammary gland function and embryogenesis in homologous systems[1][3][4]. SLC50A1 expression is significantly upregulated in human breast cancer, with serum and tissue levels linked to estrogen receptor and HER2 status and unfavorable prognosis[2]. Elevated serum SLC50A1 can serve as a diagnostic and prognostic biomarker for breast cancer, though its precise transport mechanism and therapeutic potential remain areas of ongoing study[2][4]. SLC50A1 may also play a role in other diseases such as Parkinson's disease and angiomyoma, but limited evidence exists for current targeted pharmacological interventions[4].

Other names
Sugar transporter SWEET1HsSWEET1RAG1AP1SCPSWEET1slvStromal cell proteinRAG1-activating protein 1probable sugar transporter RAG1AP1solute carrier family 50 (sugar transporter) member 1stromal cell protein
02

Mechanism of action

Not fully elucidated; potential involvement in sugar efflux and cellular carbohydrate supply[1][2]. Amplification may affect sensitivity to certain cancer therapies (e.g., ABL1 inhibitors)[2].

03

Biological functions

Carbohydrate transportGlucose transmembrane transportMay stimulate V(D)J recombination via RAG1 activation
04

Disease associations

Cancer (notably breast cancer)Parkinson's diseaseAngiomyoma
05

Safety considerations

Currently unknown; further studies required to clarify therapeutic safety and functional roles[2]
06

Interacting drugs

Bosutinib (interaction suggested via synthetic lethality in breast cancer cell models)[2]
07

Biomarkers

Serum SLC50A1 protein level (diagnostic/prognostic biomarker for breast cancer)[2]

Beyond the preview

Go deeper on Solute carrier family 50 member 1 (SLC50A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 50 member 1 (SLC50A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call